Next Article in Journal
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF)
Next Article in Special Issue
Mechanism Underlying Triple VEGFR Inhibitor Tivozanib-Induced Hypertension in Mice Model
Previous Article in Journal
Protection of H2S against Hypoxia/Reoxygenation Injury in Rat Hippocampal Neurons through Inhibiting Phosphorylation of ROCK2 at Thr436 and Ser575
Previous Article in Special Issue
Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(2), 219; https://doi.org/10.3390/ph16020219
Action Date Notes Link
article xml file uploaded 31 January 2023 12:21 CET Original file -
article xml uploaded. 31 January 2023 12:21 CET Update https://www.mdpi.com/1424-8247/16/2/219/xml
article pdf uploaded. 31 January 2023 12:21 CET Version of Record https://www.mdpi.com/1424-8247/16/2/219/pdf
article supplementary file uploaded. 31 January 2023 12:21 CET - https://www.mdpi.com/1424-8247/16/2/219#supplementary
article html file updated 31 January 2023 12:22 CET Original file -
article html file updated 1 March 2023 11:56 CET Update -
article html file updated 8 March 2023 20:44 CET Update https://www.mdpi.com/1424-8247/16/2/219/html
Back to TopTop